<?xml version="1.0" encoding="utf-8"?>
<Document>
  <Do_id>17667604</Do_id>
  <Journal>Anti-cancer drugs</Journal>
  <Doc_title>Metastatic gastrointestinal stromal tumor with long-term response after treatment with concomitant radiotherapy and imatinib mesylate.</Doc_title>
  <Doc_abstract>Total surgical excision of the tumor is considered to be the only hope in treatment of malignant mesenchymal tumors. The roles of radiotherapy and/or chemotherapy have not yet been established. We report here a case of metastatic gastrointestinal stromal tumors with a dramatic long duration of response after treatment with concurrent radiotherapy and imatinib mesylate. The patient had a long-term complete response at the radiotherapy region with concomitant imatinib therapy although previous metastatic sides persisted with partial response.</Doc_abstract>
  <Doc_ChemicalList>Antineoplastic Agents;Benzamides;Piperazines;Pyrimidines;Imatinib Mesylate</Doc_ChemicalList>
  <Doc_meshdescriptors>Antineoplastic Agents;Benzamides;Combined Modality Therapy;Gastrointestinal Neoplasms;Gastrointestinal Stromal Tumors;Humans;Imatinib Mesylate;Immunohistochemistry;Liver Neoplasms;Male;Middle Aged;Piperazines;Pyrimidines;Tomography, X-Ray Computed</Doc_meshdescriptors>
  <Doc_meshqualifiers>therapeutic use;secondary;drug therapy;pathology;therapy;secondary;therapeutic use;therapeutic use</Doc_meshqualifiers>
</Document>
